What happens if you mix COVID-19 vaccines, receiving a first dose of one jab and a second dose of a different inoculation? Scientists want to know.
Why? Because mixing doses might give governments more flexibility to stretch available vaccine supplies across populations, ensuring more people get vaccinated and doses won’t go to waste. There’s also speculation that, at least for some of the vaccines, receiving a second dose of a different vaccine might produce a stronger immune response.
Finally, if COVID-19 becomes endemic —as many experts think is likely— and people need frequent booster shots to retain immunity, then it is possible people will need to receive boosters of a different shot than they received initially.
The U.K. government is sponsoring one of the earliest and largest clinical trials of this kind of mixing, which experts call “heterologous dosing.” And the very first preliminary results from that study are in: People who received the Pfizer vaccine followed by the AstraZeneca jab or vice versa, were more likely to experience uncomfortable reactions to the second dose than people who received two doses of the same vaccine, researchers at the University of Oxford reported in a research note published in the peer-reviewed medical journal The Lancet.
These reactions included flu-like symptoms, such as fever, muscle aches, lethargy, and a general feeling of being unwell. The scientists said that none of these side effects were severe, describing them as “mild to moderate.” They also said the symptoms were short-lived, lasting at most a few days and that there had been no other safety concerns so far with mixing the Pfizer and AstraZeneca vaccines.
More frequent and pronounced reactions could lead to higher rates of absenteeism from work on the day after the second inoculation. This could be an important consideration, especially when governments were vaccinating healthcare workers, according to Matthew Snape, a University of Oxford professor of paediatrics and vaccinology who is leading the mixed dose clinical trial. The scientists also cautioned that the study only included people over the age of 50 and that it is possible that younger people might react differently….
When covid-19 struck Europe in March 2020, hospitals were plunged into a health crisis that was still badly understood. “Doctors really didn’t have a clue how to manage these patients,” says Laure Wynants, an [...]
Pfizer found to be 88 per cent effective at preventing symptomatic disease from delta variant. Two doses of Pfizer-BioNTech or AstraZeneca-Oxford's COVID-19 vaccines are nearly as effective against the highly transmissible delta coronavirus variant [...]
South African pharmaceutical company Aspen said Monday it was releasing its first batch of African-produced COVID-19 vaccines under a licensing deal with the US giant Johnson & Johnson. The Durban-based company said the first [...]
Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will cure the sick. But a virus’ main goal is to replicate and [...]
The highly transmissible delta variant of SARS-CoV-2, the coronavirus causing the disease COVID-19, is now present in 124 countries and will become the dominant strain globally in the coming months as it is outcompeting [...]
Scientists have backed proposals for Covid boosters in the autumn after blood tests on hundreds of people revealed that protective antibodies can wane substantially within weeks of second vaccine shots being given. Falls in [...]
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall [...]
CSIRO, Australia's national science agency, played an important role in evaluating heat-tolerant COVID-19 vaccine formulations developed by the Indian Institute of Science (IISc) and biotech start-up Mynvax—against all current SARS-CoV-2 variants of concern. Published [...]
Podcast – Nanovisaging 2040 How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit Humanity
Frank Boehm (NanoApps Medical Inc. Founder) in discussion with Nana Kay in a Wealth Secrets podcast. EP 19. Nanovisaging 2040. From Nana Kay: Nanovisaging 2040: How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit [...]
Canada, like several other countries, has been mixing and matching COVID-19 vaccines for weeks amid safety concerns over the AstraZeneca shot. On Monday, the chief scientist at the World Health Organization (WHO) cautioned against that approach, calling [...]
Scientists have harnessed CRISPR gene-editing technology to block the replication of the novel coronavirus in human cells — an approach that could one day serve as a new treatment for COVID-19. However, the study was performed [...]
A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as "extracellular vesicles" (EVs), in body fluids could be a biomarker for identifying types of cancer. In [...]
An important lesson for vaccine design Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not [...]
1. How COVID-19 is affecting the globe Confirmed cases of COVID-19 have passed 185 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4 million. More than 3.29 [...]
The World Health Organization (WHO) has added another COVID strain to its list of coronavirus variants to keep an eye on: the COVID-19 Lambda variant. This particular variant has now spread to more than two dozen [...]